Gene Expression Technologies Show Promise As An Aid To Breast Cancer Decision Making
Gene expression technologies show “considerable potential for improving prognostic and therapeutic prediction” in early-stage breast cancer concludes a systematic review, published in the Annals of Internal Medicine, of the three currently available commercial assays. “But more needs to be learned about the extent of that improvement….. and how they are best incorporated into decision making about current breast cancer treatment,” write the study’s authors Steven N.
More: continued here
Filed under: Breast Cancer on February 26th, 2008